Answers are grounded in this paper and cite their sources.
Experimental study reveals kappa opioid receptor activation suppresses histamine-induced scratching in mice, highlighting a claustrum-thalamic target for antipruritic therapies.
Itch, an uncomfortable sensation that induces scratching, is suppressed by activation of kappa opioid receptors (KORs). KOR agonists, such as Nalfurafine, offer potent central antipruritic effects, yet the underlying mechanisms are not fully understood. In this study, we report the important role of glutamatergic neurons in the claustrum (CLA) in itch modulation. Chemogenetic inhibition of these neurons significantly reduces histamine-induced scratching behavior, whereas their activation heightens scratching behavior. These CLA Glu neurons connect to the mediodorsal thalamus (MD), forming a pathway that modulates itch sensations. Optogenetic manipulation of the CLA Glu -MD pathway demonstrates that its inhibition decreases scratching behavior, whereas activation increases it. Notably, CLA Glu neurons highly express KORs, and treatment with Nalfurafine markedly inhibits histamine-induced CLA Glu neuronal activation. Conditional knockdown of KORs in CLA Glu neurons or the CLA Glu -MD circuit diminishes Nalfurafine’s antipruritic effects. These findings provide insight into the neural circuits involved in histaminergic itch and the action of KOR agonists.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: